Show simple item record

Treating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trial

dc.contributor.authorHu, X-Yen_US
dc.contributor.authorOliver, Ten_US
dc.contributor.authorWillcox, Men_US
dc.contributor.authorSimpson, Cen_US
dc.contributor.authorThorne, Ken_US
dc.contributor.authorTrill, Jen_US
dc.contributor.authorFrancis, Nen_US
dc.contributor.authorStuart, Ben_US
dc.contributor.authorThomas, Men_US
dc.contributor.authorLittle, Pen_US
dc.contributor.authorLiu, J-Pen_US
dc.contributor.authorGriffiths, Gen_US
dc.contributor.authorMoore, Men_US
dc.date.accessioned2023-01-10T14:41:30Z
dc.date.available2022-12-01en_US
dc.date.issued2022en_US
dc.identifier.otherARTN 262en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/83623
dc.relation.ispartofPILOT AND FEASIBILITY STUDIESen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectHerbal medicineen_US
dc.subjectExacerbationen_US
dc.subjectChronic obstructive pulmonary diseaseen_US
dc.subjectRandomised controlled trialen_US
dc.subjectFeasibilityen_US
dc.subjectQualitativeen_US
dc.titleTreating Acute EXacerbations of COPD with Chinese HerbAL MedIcine to aid AntiBiotic Use Reduction (EXCALIBUR): study protocol of a randomised double-blind, placebo-controlled feasibility trialen_US
dc.typeArticle
dc.identifier.doi10.1186/s40814-022-01224-8en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000901121800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue1en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume8en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States